06 December 2021

Investor consortium (ECM, PINOVA, Gilde) acquires DETAX

King & Wood Mallesons (KWM) advised funds managed by ECM Equity Capital Management GmbH (ECM), PINOVA Capital GmbH (PINOVA) and Gilde Healthcare (the investment consortium) on the acquisition of a majority stake in DETAX Group. The investor consortium supports DETAX and the management team in succession planning through a management buy-out. The transaction is still subject to approval of the relevant antitrust authorities.

DETAX is a specialist in medical polymer materials and a leading supplier of biocompatible silicones as well as light-curing 3D resins for medical applications in the dental and audio sectors. Together, the investors and DETAX intend to drive further the successful growth of the company.

ECM is a trusted growth partner for mid-sized enterprises and entrepreneurs in German-speaking Europe. The ECM funds invest primarily in leading mid-market companies with attractive growth potential in the context of ownership successions, partnership transactions and corporate spin-offs.

PINOVA Capital is an independent private equity firm investing in high-growth technology companies in German-speaking regions. PINOVA Capital focuses on “Mittelstand” companies with sales between €10 million and €75 million in the sectors industrial technology and information technology, characterized by significant growth potential, sustainable competitive advantages and a strong market position in their niche.

Gilde Healthcare is a specialized healthcare investor with two fund strategies: Venture & Growth and Private Equity. The firm is headquartered in Utrecht (The Netherlands) with local offices in Frankfurt (Germany) and Cambridge (United States). The Private Equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market. Gilde Healthcare Venture & Growth invests in medtech, healthtech and therapeutics in Europe and North America.

Advisors to ECM Equity Capital Management GmbH, PINOVA Capital GmbH, Gilde Healthcare: 

Dr. Michael RoosDr. Tilmann BeckerDr. Peter PolkeMarkus Herz, Dr. Katrin Thoma, Damian Thiele, Hanno Brandt, Simon Brandt (PSL) (all Corporate/M&A), Martin Gliewe (Employment), Markus Hill, Viktoria Rosbach (both Tax), Tilman Siebert (Antitrust/Competition) 

The KWM team was supported by Dr. Christian Rybak and Nicole Schwiegk (both Ehlers, Ehlers & Partner) with regard to regulatory aspects (including medical law).

Media Contact

Share on LinkedIn Share on Facebook Share on Twitter
    You might also be interested in

    KWM advised the Young Fashion Group and its management on the acquisition of Framode GmbH (Germany), Dimodes S.A. (Spain), and Bianca S.A. (Portugal) as well as the parallel establishment of a master...

    09 December 2021

    KWM advised a fund managed by STAR Capital Partnership LLP on the acquisition of the business division VINCORION from German listed company Jenoptik AG.

    02 December 2021

    The international KWM team successfully advised Walden International on its investment in Memphis Eletronic as well as on foreign direct investment (FDI) proceedings in Germany.

    30 November 2021

    KWM has advised Nachfolgepartner AG on a partnership investment with Chromedia Dialogmarketing GmbH.

    20 October 2021

    You may also be interested in...

    This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

    For more information on which cookies we use then please refer to our Cookie Policy.